Cheng YC - Search Results

1

X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance.

Park SY, Lam W, Cheng YC. Park SY, et al. Among authors: cheng yc. Cancer Res. 2002 Jan 15;62(2):459-65. Cancer Res. 2002. PMID: 11809696

2

Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates.

Liou JY, Dutschman GE, Lam W, Jiang Z, Cheng YC. Liou JY, et al. Among authors: cheng yc. Cancer Res. 2002 Mar 15;62(6):1624-31. Cancer Res. 2002. PMID: 11912132

3

Novel mode of action of tylophorine analogs as antitumor compounds.

Gao W, Lam W, Zhong S, Kaczmarek C, Baker DC, Cheng YC. Gao W, et al. Among authors: cheng yc. Cancer Res. 2004 Jan 15;64(2):678-88. doi: 10.1158/0008-5472.can-03-1904. Cancer Res. 2004. PMID: 14744785

4

Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines.

Kim TE, Park SY, Hsu CH, Dutschman GE, Cheng YC. Kim TE, et al. Among authors: cheng yc. Mol Pharmacol. 2004 Aug;66(2):285-92. doi: 10.1124/mol.66.2.285. Mol Pharmacol. 2004. PMID: 15266019

5

Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.

Park SY, Cheng YC. Park SY, et al. Among authors: cheng yc. Cancer Res. 2005 May 1;65(9):3894-902. doi: 10.1158/0008-5472.CAN-04-4014. Cancer Res. 2005. PMID: 15867389

6

ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin.

Park SY, Leung CH, Cheng YC. Park SY, et al. Among authors: cheng yc. Mol Pharmacol. 2008 Jun;73(6):1829-37. doi: 10.1124/mol.107.044438. Epub 2008 Mar 18. Mol Pharmacol. 2008. PMID: 18349103

7

Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.

Lam W, Bussom S, Cheng YC. Lam W, et al. Among authors: cheng yc. Mol Cancer Ther. 2009 Feb;8(2):415-23. doi: 10.1158/1535-7163.MCT-08-0692. Epub 2009 Feb 10. Mol Cancer Ther. 2009. PMID: 19208827

8

Multikinase inhibitor sorafenib induces skin toxicities in tumor-bearing mice.

Tian A, Lu H, Zhang J, Fu S, Jiang Z, Lam W, Guan F, Chen L, Feng L, Cheng Y. Tian A, et al. Cancer Chemother Pharmacol. 2018 Jun;81(6):1025-1033. doi: 10.1007/s00280-018-3575-y. Epub 2018 Apr 9. Cancer Chemother Pharmacol. 2018. PMID: 29633006

9

Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake.

Lam W, Chen C, Ruan S, Leung CH, Cheng YC. Lam W, et al. Among authors: cheng yc. Mol Pharmacol. 2005 Feb;67(2):408-16. doi: 10.1124/mol.104.007120. Epub 2004 Nov 11. Mol Pharmacol. 2005. PMID: 15539640

10

Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens.

Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Leung CH, et al. Among authors: cheng yc. Mol Pharmacol. 2005 Aug;68(2):286-97. doi: 10.1124/mol.105.012765. Epub 2005 May 4. Mol Pharmacol. 2005. PMID: 15872117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,536 results

Search Page

Filters